Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.80 USD
Change Today +0.0168 / 2.15%
Volume 55.9K
HNSN On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 5:20 PM 03/26/15 All times are local (Market data is delayed by at least 15 minutes).

hansen medical inc (HNSN) Snapshot

Open
$0.79
Previous Close
$0.78
Day High
$0.80
Day Low
$0.74
52 Week High
04/2/14 - $2.84
52 Week Low
12/24/14 - $0.52
Market Cap
106.1M
Average Volume 10 Days
144.4K
EPS TTM
$-0.47
Shares Outstanding
133.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HANSEN MEDICAL INC (HNSN)

Related News

No related news articles were found.

hansen medical inc (HNSN) Related Businessweek News

No Related Businessweek News Found

hansen medical inc (HNSN) Details

Hansen Medical, Inc. develops, manufactures, and sells medical robotics designed for the positioning, manipulation, and control of catheters and catheter-based technologies in the United States and internationally. It offers Sensei systems and Artisan Control Catheters for manipulation, positioning, and control of mapping catheters during electro-physiology procedures; and CoHesion 3D Visualization Module, a software interface that provides physicians with 3D visualization to augment their ability to move a catheter throughout the atria, as well as increase control over placement of the catheter in specific locations. The company also provides Magellan Robotic System, which controls the proprietary Magellan Robotic Catheter, a telescoping and robotically steerable catheter that facilitates remote catheter navigation and vessel cannulation, and provides robotically stabilized sheath for manual delivery of therapeutic devices. It markets, sells, and supports its products through direct sales force, distributors, and sales representatives. Hansen Medical, Inc. was founded in 2002 and is headquartered in Mountain View, California.

169 Employees
Last Reported Date: 03/16/15
Founded in 2002

hansen medical inc (HNSN) Top Compensated Officers

Chief Operating Officer
Total Annual Compensation: $275.0K
Vice President of Marketing & Business Develo...
Total Annual Compensation: $241.5K
Senior Vice President of Global Sales
Total Annual Compensation: $230.0K
Compensation as of Fiscal Year 2013.

hansen medical inc (HNSN) Key Developments

Hansen Medical Drums Up $35 Million Private Placement

Hansen Medical announced that it drummed up $35 million for its robot-assisted surgery devices from a syndicate of investors that includes its founder, a director and a pair of hedge funds.

Hansen Medical Announces Completion of First Clinical Procedures with Magellan Robotic System in the Middle East

Hansen Medical, Inc. announced the completion of the first clinical procedures with the Magellan Robotic System in the Middle East. The team led by Dr. Iyad Feteih, Interventional Radiologist and Assistant Hospital Director, performed five procedures with Magellan at King Fahd Hospital (MOH) in Jeddah, Kingdom of Saudi Arabia. The Magellan system was installed in late 2014 in collaboration with AFYA Medical Group, Hansen Medical's exclusive distribution partner in Kingdom of Saudi Arabia and United Arab Emirates. The Magellan Robotic System is an advanced technology that drives the Magellan Robotic Catheters during endovascular procedures. Magellan is designed to offer procedural predictability, control, and catheter stability to physicians as they remotely navigate the robotic catheter through the vasculature. Magellan's remote workstation allows physicians to navigate through the vasculature while seated away from the radiation field, potentially reducing physicians' radiation exposure and procedural fatigue.

Hansen Medical, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

Hansen Medical, Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported total revenues of $5,032,000 compared to $5,620,000 for the same period of last year. Loss from operations was $10,692,000 compared to $10,653,000 for the same period of last year. Loss before income taxes was $11,927,000 compared to $11,866,000 for the same period of last year. Net loss was $11,917,000 compared to $11,888,000 for the same period of last year. Basic and diluted net loss per share was $0.09 compared to $0.12 for the same period of last year. Non-GAAP loss from operation was $9,058,000 compared to $9,445,000 for the same period of last year. Non-GAAP net loss was $10,283,000 compared to $10,680,000 for the same period of last year. Non-GAAP diluted loss per share was $0.08 compared to $0.11 for the same period of last year. Total revenue decreased 10% primarily due to robotic systems in backlog as of December 31, 2014. For the full year, the company reported total revenues of $19,495,000 compared to $16,982,000 for the same period of last year. Loss from operations was $46,284,000 compared to $48,903,000 for the same period of last year. Loss before income taxes was $54,218,000 compared to $55,607,000 for the same period of last year. Net loss was $54,246,000 compared to $55,722,000 for the same period of last year. Basic and diluted net loss per share was $0.46 compared to $0.70 for the same period of last year. Non-GAAP loss from operation was $41,661,000 compared to $39,190,000 for the same period of last year. Non-GAAP net loss was $46,709,000 compared to $44,074,000 for the same period of last year. Non-GAAP diluted loss per share was $0.40 compared to $0.56 for the same period of last year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HNSN:US $0.80 USD +0.0168

HNSN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ABIOMED Inc $69.03 USD -1.49
Corindus Vascular Robotics Inc $4.25 USD 0.00
LeMaitre Vascular Inc $8.25 USD -0.10
Stereotaxis Inc $2.07 USD -0.03
Spectranetics Corp/The $34.45 USD +0.22
View Industry Companies
 

Industry Analysis

HNSN

Industry Average

Valuation HNSN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.3x
Price/Book 13.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HANSEN MEDICAL INC, please visit www.hansenmedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.